Automated cell manufacturing company Mytos has partnered with Aspen Neuroscience to automate the production of customized cells for Aspen’s Parkinson’s disease therapy. Under the agreement, Aspen will use Mytos’s iDEM technology to manage cell production in its California-based factory. The deal allows Aspen to streamline its cell production process, reducing labor and enabling multibatch handling to increase capacity. A manual iDEM alternative can be learned by a single operator.
Dispersed responsibility, lack of asset inventory is causing gaps in medical device cybersecurity
Witnesses at a House hearing on medical device cybersecurity highlighted the need for better tracking of devices and their vulnerability to cyber threats. They noted
